title: [Follow up studies as a condition for drug subsidizing].
authors: helle.kieler@ki.se
authors: Helle
authors: H
authors: Kieler
authors: Anders
authors: A
authors: Ekbom
authors: Michael
authors: M
authors: Fored
authors: Scott M
authors: SM
authors: Montgomery
authors: Björn
authors: B
authors: Wettermark
mesh_terms: D018849:Controlled Clinical Trials as Topic / Q000592:standards; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry; D005500:Follow-Up Studies; D006801:Humans; D007348:Insurance, Health / Q000191:economics; D017063:Outcome Assessment, Health Care; D004364:Pharmaceutical Preparations / Q000191:economics*
chemical_list: D004364:Pharmaceutical Preparations